Coronary arterial thrombolysis with low-dose synergistic combinations of recombinant tissue-type plasminogen activator (rt-PA) and recombinant single-chain urokinase-type plasminogen activator (rscu-PA) for acute myocardial infarction

This publication has 17 references indexed in Scilit:

• Coronary thrombolysis in patients with acute myocardial infarction by intravenous infusion of synergic thrombolytic agents
  American Heart Journal, 1986
• Coronary thrombolysis with recombinant single-chain urokinase-type plasminogen activator in patients with acute myocardial infarction.
  Circulation, 1986
• Dose-dependent thrombolysis, pharmacokinetics and hemostatic effects of recombinant human tissue-type plasminogen activator for coronary thrombosis
  The American Journal of Cardiology, 1986
• Synergism of thrombolytic agents in vivo.
  Circulation, 1986
• Analysis of coagulation and fibrinolysis during intravenous infusion of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction.
  Circulation, 1986
• Cloning and Expression of the Gene for Pro-urokinase in Escherichia coli
  Bio/Technology, 1985
• The expected effect of a combination of agents: the general solution
  Journal of Theoretical Biology, 1985
• Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli
  Nature, 1983
• Inhibition of plasmin by normal and antiplasmin-depleted human plasma
  Thrombosis Research, 1976
• Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
  Acta Haematologica, 1957